LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Strona główna・Stock List・Ascendis Pharma A-S ADR

Ascendis Pharma A-S ADR

Closed

SectorHealthcare

228.97 1.03

Buy Sell

Overview

Share price change

24h

Current

Min

221.12

Max

230.71

Key metrics
By Trading Economics
Income	28M -33M
Sales	32M 245M
Profit margin	-13.56
Employees	1,189
EBITDA	68M 15M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+28.01% upside

Dividends
By Dow Jones
Next Earnings	30 kwi 2026

Market Stats
By TradingEconomics
Market Cap	-288M 13B
Previous open	227.94
Previous close	228.97

News Sentiment

By Acuity

54%

46%

290 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

157.66 / 167.29 Support & Resistance

Ascendis Pharma A-S ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 lut 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

19 lut 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19 lut 2026, 23:39 UTC

Acquisitions, Mergers, Takeovers

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19 lut 2026, 23:38 UTC

Earnings

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19 lut 2026, 23:38 UTC

Earnings

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19 lut 2026, 23:38 UTC

Earnings

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19 lut 2026, 23:37 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19 lut 2026, 23:34 UTC

Earnings

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19 lut 2026, 23:34 UTC

Earnings

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19 lut 2026, 23:33 UTC

Earnings

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19 lut 2026, 23:33 UTC

Earnings

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19 lut 2026, 22:13 UTC

Market Talk

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19 lut 2026, 22:08 UTC

Earnings

Fairfax Financial 4Q Rev $8.11B >FFH.T

19 lut 2026, 22:07 UTC

Earnings

Eldorado Gold 4Q EPS $1.19 >ELD.T

19 lut 2026, 22:06 UTC

Earnings

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19 lut 2026, 22:05 UTC

Earnings

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19 lut 2026, 22:05 UTC

Earnings

Eldorado Gold 4Q Rev $577.2M >ELD.T

19 lut 2026, 22:04 UTC

Earnings

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19 lut 2026, 22:04 UTC

Earnings

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19 lut 2026, 21:50 UTC

Market Talk

Earnings

Tech, Media & Telecom Roundup: Market Talk

19 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19 lut 2026, 21:43 UTC

Earnings

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19 lut 2026, 21:42 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19 lut 2026, 21:42 UTC

Earnings

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19 lut 2026, 21:41 UTC

Earnings

Correct: St Barbara 1H Net Loss A$249,000

19 lut 2026, 21:40 UTC

Earnings

St Barbara 1H Net Loss A$249 Million

19 lut 2026, 21:39 UTC

Earnings

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19 lut 2026, 21:37 UTC

Earnings

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19 lut 2026, 21:37 UTC

Earnings

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Peer Comparison

Price change

Ascendis Pharma A-S ADR Forecast

Price Target

By TipRanks

28.01% upside

12 Months Forecast

Average 290.36 USD 28.01%

High 342 USD

Low 250 USD

Based on 11 Wall Street analysts offering 12 month price targets forAscendis Pharma A-S ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Ascendis Pharma A-S ADR - Dist in the past 3 months.

Technical Score

By Trading Central

157.66 / 167.29Support & Resistance

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

290 / 351 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Ascendis Pharma A-S ADR

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.